First‐line vascular endothelial growth factor inhibitors for advanced renal cell carcinoma and the impact of new agents entering the treatment paradigm

DOI: 10.1111/bju.13954

,

Issn Print: 1464-4096

Publication Date: 2017/12/01

Rohit Jain; Saby George

Author Information: Roswell Park Institute


		Checking for direct PDF access through Ovid

View on Journal Site

Abstract unavailable for this article.


		Loading Related Articles